Proinflammatory cytokines in heart disease

Area of Science:

• Cardiovascular Science
• Immunology
• Molecular Medicine

Background:

• Proinflammatory cytokines, including interleukin-1 (IL-1) and tumor necrosis factor (TNF), significantly impact cardiovascular health.
• While their roles in sepsis are well-established, their involvement in atherosclerosis, myocardial infarction, and heart failure is a recent area of investigation.
• Cytokines also exhibit cardioprotective effects, particularly concerning acute coronary syndromes and ischemia-induced myocardial suppression.

Purpose of the Study:

• To review the multifaceted roles of proinflammatory cytokines in cardiovascular diseases.
• To highlight the potential of anticytokine therapies for treating heart conditions.
• To discuss current and emerging therapeutic strategies targeting cytokine pathways.

Main Methods:

• Literature review focusing on cytokine involvement in cardiovascular pathogenesis.
• Analysis of research on acute coronary syndromes and myocardial function.
• Examination of existing and investigational anticytokine treatments.

Main Results:

• Cytokines are implicated in the pathogenesis of coronary artery atherosclerosis, myocardial infarction, and heart failure.
• Cytokine-targeted therapies, such as TNF-alpha neutralization and IL-1 receptor blockade, are effective in other inflammatory conditions.
• Novel oral agents targeting IL-1beta-converting enzyme and p38 mitogen-activated protein kinase are under clinical investigation.

Conclusions:

• Cytokines are critical mediators in various cardiovascular diseases, presenting therapeutic targets.
• Anticytokine therapies hold significant promise for managing heart disease.
• Ongoing clinical trials for novel oral agents suggest a future for targeted cytokine modulation in cardiology.